Ruiz, Sitti Khadeejah .
HRN: 21-73-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/09/2022
08/16/2022
IV
300
Q6h
Laceration
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes